全文获取类型
收费全文 | 32911篇 |
免费 | 2981篇 |
国内免费 | 106篇 |
专业分类
耳鼻咽喉 | 332篇 |
儿科学 | 987篇 |
妇产科学 | 617篇 |
基础医学 | 4555篇 |
口腔科学 | 779篇 |
临床医学 | 3799篇 |
内科学 | 6547篇 |
皮肤病学 | 427篇 |
神经病学 | 3550篇 |
特种医学 | 995篇 |
外国民族医学 | 2篇 |
外科学 | 4163篇 |
综合类 | 587篇 |
一般理论 | 42篇 |
预防医学 | 3582篇 |
眼科学 | 821篇 |
药学 | 2199篇 |
1篇 | |
中国医学 | 66篇 |
肿瘤学 | 1947篇 |
出版年
2023年 | 168篇 |
2022年 | 260篇 |
2021年 | 622篇 |
2020年 | 367篇 |
2019年 | 614篇 |
2018年 | 620篇 |
2017年 | 545篇 |
2016年 | 579篇 |
2015年 | 622篇 |
2014年 | 965篇 |
2013年 | 1343篇 |
2012年 | 2036篇 |
2011年 | 2225篇 |
2010年 | 1122篇 |
2009年 | 1036篇 |
2008年 | 1848篇 |
2007年 | 1867篇 |
2006年 | 1844篇 |
2005年 | 1837篇 |
2004年 | 1773篇 |
2003年 | 1712篇 |
2002年 | 1596篇 |
2001年 | 706篇 |
2000年 | 733篇 |
1999年 | 666篇 |
1998年 | 418篇 |
1997年 | 360篇 |
1996年 | 349篇 |
1995年 | 277篇 |
1994年 | 257篇 |
1993年 | 260篇 |
1992年 | 443篇 |
1991年 | 421篇 |
1990年 | 429篇 |
1989年 | 349篇 |
1988年 | 397篇 |
1987年 | 353篇 |
1986年 | 334篇 |
1985年 | 314篇 |
1984年 | 264篇 |
1983年 | 226篇 |
1982年 | 199篇 |
1981年 | 198篇 |
1980年 | 191篇 |
1979年 | 226篇 |
1978年 | 169篇 |
1977年 | 150篇 |
1976年 | 143篇 |
1974年 | 154篇 |
1973年 | 140篇 |
排序方式: 共有10000条查询结果,搜索用时 2 毫秒
101.
102.
Claudio N Soares Brian J Murray 《Psychiatric Clinics of North America》2006,29(4):1095-113; abstract xi
Sleep disorders are more prevalent in women than in men. Sex hormones modulate sleep-wake behaviors and mood and may contribute to heightened risk across the life cycle of women. Sleep disorders may have a unique expression in women, emerging throughout their reproductive life cycle. These conditions require careful treatment strategy to manage medical, hormonal, and behavioral contributing factors to poor sleep efficiency and impaired quality of life. This review focuses on clinical evidence for sleep disorders in women and discusses existing evidence of risk factors and treatment options for insomnia and sleep-disordered breathing in women. 相似文献
103.
104.
105.
106.
M E Watts J C Murray K A Smith M Woodcock 《International journal of radiation oncology, biology, physics》1992,22(3):431-435
Flavone acetic acid (FAA) causes significant regression of larger established tumors in murine systems in vivo, but is only slightly toxic in vitro. This in vivo effect is thought to be indirect, or immunological, rather than a direct cytotoxic effect on tumor cells. Using the WHFIB fibrosarcoma, which grows both in vivo and in vitro, and the murine endothelial cell line B10, we have studied the effect of FAA on the survival of tumor and endothelial cells in vitro. The times taken for 1 mg ml-1 FAA to reduce survival to 0.1 surviving fraction were 63 hr for B10 and greater than 85 hr for WHFIB in vitro. WHFIB tumors in vivo were more sensitive than tumor cells in vitro, a single dose of 150 mg kg-1 FAA inducing a tumor growth delay of 10 days at treatment size + 2 mm. As FAA is more toxic to tumor-bearing animals than to those which are non-tumor bearing the effect of tumor conditioned medium on the cytotoxicity of FAA toward B10 cells was studied; no enhanced effect was seen. As FAA is only weakly cytotoxic in vitro to endothelial cells, and even less so to tumor cells, sublethal effects of FAA on endothelial cell function in vitro were studied. The permeability of monolayers of human unbilical vein endothelial cells (HUVEC) in vitro is transiently increased by FAA. Also, procoagulant activity of HUVEC is induced by FAA and this activity is further enhanced in the presence of a factor isolated from Meth-A tumor cells. 相似文献
107.
J P Muizelaar M Vermeulen H van Crevel A Hijdra J van Gijn G M Teasdale K W Lindsay G D Murray 《Clinical neurology and neurosurgery》1988,90(3):203-207
The outcome at three months after aneurysmal SAH in a group of older patients and a group of younger patients is compared. The patients were admitted within 72 hours of their SAH. Of 61 patients 66 years of age and older, comprising 13% of the whole patient group, 52% died, 12% remained dependent and 36% became independent. In the younger group, 55% had an independent outcome (p less than 0.01). In contrast to what we expected in the older patient group, not extracranial, but intracranial events (re-bleeds, infarcts, hydrocephalus) were by far the most frequent cause of deterioration. 相似文献
108.
109.
Does beta adrenergic blockade influence the prognostic implications of post-myocardial infarction exercise testing? 总被引:1,自引:0,他引:1
D P Murray L B Tan M Salih P Weissberg R G Murray W A Littler 《British heart journal》1988,60(6):474-479
The influence of beta blockade on the ability of ST depression, during pre-discharge exercise testing, to predict coronary anatomy and subsequent complications was studied in 300 consecutive post-infarct patients, 125 of whom underwent cardiac catheterisation. At the time of exercise 62 patients were taking a beta blocker. The exercise test had a higher sensitivity in predicting multivessel disease in patients who were not taking beta blockers than in patients who were (95% v 76%). beta Blockade did not, however, influence the ability of the test to identify patients at risk of subsequent cardiac events (sensitivity 84% and 85% respectively). These results suggest that it is not necessary to stop treatment with beta blockers before predischarge exercise testing of patients who have had an acute myocardial infarction. 相似文献
110.
Dr. Mary S. Brady MD Carol F. Garfein MBA Jeanne A. Petrek MD Murray F. Brennan MD 《Annals of surgical oncology》1994,1(1):66-72
Background: Many patients treated for breast cancer with radiotherapy will survive their disease and be at risk for treatment-related sarcoma for many years.
Methods: In order to identify patients with post-treatment sarcoma and define this disease, we examined the records of 99 patients treated for sarcoma with a history of antecedent breast carcinoma. Of these patients, 51 were felt to have a sarcoma unrelated to breast cancer treatment and 48 were felt to have a treatment-related sarcoma (secondary to lymphedema and/or radiation).
Results: Lymphangiosarcoma of the extremity was the most common histologic subtype of post-treatment sarcoma, accounting for 22 of 48 cases (46%). Twenty-six patients (54%) developed nonlymphangiosarcoma post-treatment sarcoma; all of these were radiation-associated sarcomas. The median latency interval between the diagnosis of breast cancer and the development of sarcoma was 11 years (range 4–44) and was not different between the two groups. However, patients with nonlymphangiosarcoma were significantly younger when diagnosed with breast cancer than were those with lymphangiosarcoma of the extremity (median 43 vs. 51 years, p<0.001). The survival of all 48 patients was poor: 5-year survival was 29%. Five-year survival of patients with other types of post-treatment sarcoma was just as poor as those with lymphangiosarcoma of the extremity (30% vs. 28%, p=0.98).
Conclusions: Patients who develop sarcoma after treatment for breast cancer have a poor prognosis whether it occurs as Stewart-Treves syndrome or other types of post-treatment sarcoma. Younger patients may be at higher risk than are older patients for the development of nonlymphangiosarcoma post-treatment sarcoma.Presented at the 46th Annual Cancer Symposium of the Society of Surgical Oncology, Los Angeles, March 18–21, 1993. 相似文献